Japan Viscosupplementation Market (2026-2032) | Competitive Landscape, Segmentation, Value, Share, Industry, Growth, Size & Revenue, Companies, Trends, Analysis, Forecast, Outlook

Market Forecast By Product Type (Single Injection, Three Injection, Five Injection), By End User (Hospitals, Orthopedic Clinics/ASCs) And Competitive Landscape

Product Code: ETC7751250 Publication Date: Sep 2024 Updated Date: Oct 2026 Product Type: Market Research Report
Publisher: 6Wresearch Author: Summon Dutta No. of Pages: 110 No. of Figures: 55 No. of Tables: 11
Market Size, 2025 USD 81.70 Million
Market Size, 2032 USD 132 Million
CAGR, 2026–2032 7.1%

Japan Viscosupplementation Market Size & Growth Rate

Japan Viscosupplementation Market Size & Growth Rate

According to 6Wresearch internal database and industry insights, the Japan Viscosupplementation Market was valued at USD 81.70 Million in 2025 and is projected to reach USD 132 Million by 2032, growing at a CAGR of approximately 7.1% during 2026–2032.

Japan Viscosupplementation Market Highlights

Report Metric Details
Report Name Japan Viscosupplementation Market (2026-2032)
Market Size 2025 USD 81.70 Million
Market Size 2032 USD 132 Million
Absolute Growth 2025–2032 USD 50.30 Million
CAGR 2026–2032 7.1%
Peak Annual Growth 8.1% in 2031
Forecast Period 2026–2032
Historical Data 2022–2025
Base Year 2025
Leading Product Type, 2025 Single Injection (54% share)
Leading End User, 2025 Hospitals (60% share)
Fastest-Growing Product Type Three Injection (9.9% CAGR)
Fastest-Growing End User Orthopedic Clinics/ASCs (9.1% CAGR)
Growing Sector Orthopedic Care
Key End Users Hospitals, Orthopedic Clinics, ASCs, Healthcare Providers

Japan Viscosupplementation Market Year-wise Growth Rate and Key Drivers (2022–2032)

This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.

Japan Viscosupplementation Market Year-wise Growth Rate and Key Drivers (2022–2032)

Below, each year's estimated growth is shown next to the factor that most influenced it.

Year Estimated Annual Growth (%) Market Rationale
2022 8.3 The market experienced steady growth due to increased awareness of treatment options.
2023 8.6 Demand rose as more healthcare providers adopted viscosupplementation techniques.
2024 9.1 The introduction of new product types contributed to higher sales figures.
2025 9.4 Growth peaked as hospitals expanded their treatment offerings.
2026 5.6 Growth is expected to slow as market saturation begins to affect new purchases.
2027 6.3 Increased investment in orthopedic clinics will drive demand higher again.
2028 6.8 The rising elderly population will further boost the need for joint treatments.
2029 7.2 Advancements in product efficacy will attract more buyers to the market.
2030 7.6 The trend towards minimally invasive procedures will continue to support growth.
2031 8.1 Demand will surge again as healthcare providers expand their service capacities.
2032 8.1 Growth will stabilise as the market adjusts to new treatment standards.

Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.

Japan Viscosupplementation Market Synopsis

Viscosupplementation involves injecting hyaluronic acid into joints to alleviate pain and improve mobility, particularly for osteoarthritis patients. The Japan Viscosupplementation Market is projected to grow due to an ageing population, expected to reach 28% by 2032, and increased healthcare spending, which hit USD 500 billion in 2022. Hospitals are investing in advanced treatment options, while orthopedic clinics are adopting new technologies to improve patient outcomes, particularly three-injection therapies that are gaining popularity.

Market Dynamics Impact Analysis (2026–2032)

Factor Type Impact Primary Segment Affected
Increasing prevalence of osteoarthritis among the ageing population Driver High Single Injection
Technological advancements in viscosupplementation products Driver High Three Injection
Rising patient awareness about treatment options Opportunity High Five Injection
Expansion of orthopedic clinics and ASCs Opportunity High Orthopedic Clinics/ASCs
Regulatory hurdles for new product approvals Restraint Medium Single Injection
High costs associated with advanced viscosupplementation therapies Restraint Medium Three Injection
Limited reimbursement for certain viscosupplementation treatments Challenge High Five Injection
Competition from alternative therapies such as stem cell treatments Challenge Medium Orthopedic Clinics/ASCs

Evaluation of Drivers in Japan Viscosupplementation Market (2026–2032)

The table below links each growth driver to the segment it affects and the evidence for it.

Drivers Primary Segment Affected Why It Matters (Evidence)
Growing elderly population Single Injection The elderly demographic is increasingly seeking pain relief solutions, with approximately 28% of the population over 65 years old.
Technological advancements in product formulations Three Injection Innovations in hyaluronic acid formulations have improved efficacy, leading to a 30% increase in adoption rates among clinics.
Increased healthcare expenditure Five Injection Healthcare spending in Japan reached USD 500 billion in 2022, facilitating greater access to advanced treatments.
Rising awareness of treatment options among patients Orthopedic Clinics/ASCs Patient education initiatives have led to a 40% increase in inquiries regarding viscosupplementation.
Expansion of hospital networks offering advanced treatments Single Injection The number of hospitals providing viscosupplementation services grew by 15% in the past three years.

Several shifts outside the market lift sales. The growing elderly population, which constitutes approximately 28% of Japan's demographic, drives demand for joint pain relief solutions. Technological advancements in product formulations have improved efficacy, resulting in a marked increase in adoption rates among clinics. Healthcare expenditure reached USD 500 billion in 2022, facilitating access to advanced treatments. The expansion of hospital networks providing these services has surged over the past three years, stimulating demand.

Evaluation of Restraints in Japan Viscosupplementation Market

These are the pressures that could keep growth below its potential.

Market Restraint Primary Segment Affected Why It Matters (Evidence)
Regulatory hurdles for new product approvals Single Injection Stringent regulations slow down the introduction of new products, affecting market growth.
High costs associated with advanced viscosupplementation therapies Three Injection Prices for new therapies can exceed USD 1,500 per treatment cycle, limiting patient access.
Limited reimbursement for certain viscosupplementation treatments Five Injection Insurance coverage varies, with some treatments not being reimbursed, affecting patient uptake.
Competition from alternative therapies such as stem cell treatments Orthopedic Clinics/ASCs Emerging therapies present a cost-effective alternative, potentially diverting patients away from viscosupplementation.
Market saturation in urban areas Single Injection High competition in metropolitan regions leads to price wars, impacting profitability for providers.

Japan Viscosupplementation Market Challenges

Producers experience a 20% drop in profit margins due to intense competition from alternative therapies. Importers struggle with a shortage of skilled workers, leading to delays in product availability that extend lead times by three weeks. Buyers are facing rising costs as raw material prices fluctuate, with some reporting increases of up to 15% over the past year. Regulatory barriers hinder market entry for new products, causing approval times to stretch by six months, which impacts product availability for clinics and hospitals.

Trends in the Japan Viscosupplementation Market

Four trends stand out in the Japan Viscosupplementation Market.

  • Shift towards Three Injection Protocols: The introduction of three-injection protocols has gained traction since 2025, with adoption rates increasing significantly. This shift allows for prolonged pain relief, appealing to patients seeking effective long-term solutions.
  • Growing Preference for Minimally Invasive Procedures: In 2023, a majority of patients preferred minimally invasive treatments, reflecting a broader trend towards less invasive options. This preference is reshaping service offerings in hospitals and clinics across Japan.
  • Increased Focus on Patient Education: Since 2022, healthcare providers have intensified efforts to educate patients about viscosupplementation, resulting in a significant rise in inquiries. This trend is leading to greater patient engagement and treatment uptake.
  • Expansion of Orthopedic Clinics: The number of orthopedic clinics has increased significantly since 2020, driven by rising demand for joint treatments. This growth indicates a shift in how patients access care, with more options available.

Investment Opportunities in the Japan Viscosupplementation Market

The openings below show where demand in the Japan Viscosupplementation Market is visible and how suppliers can enter.

  • Timing for Investment in Advanced Therapies: With healthcare spending reaching USD 500 billion in 2022, now is an opportune time to invest in advanced viscosupplementation therapies. Hospitals are increasingly looking to improve their treatment offerings.
  • Orthopedic Clinics Seeking New Solutions: Orthopedic clinics are actively seeking viscosupplementation products, particularly three-injection protocols, to meet rising patient demand. Partnering with local distributors can facilitate market entry.
  • Clear Approval Pathways for New Products: The recent revisions to the PMD Act create clearer pathways for product approvals. Companies can use this to introduce new viscosupplementation therapies more efficiently.
  • Expansion in Urban Healthcare Facilities: Urban healthcare facilities are expanding their service offerings, with a notable increase in new clinics. Targeting these areas with innovative products presents significant growth opportunities.

Government Initiatives in the Japan Viscosupplementation Market

The PMD Act, revised in 2014, streamlines the approval process for viscosupplementation products, ensuring that new therapies can be introduced more quickly. This measure complements the NHI drug price standard, which sets reimbursement prices for these therapies, allowing providers to recover costs effectively.

Healthcare providers benefit from the Medical Care Act, which mandates standards for facilities and staffing. This act ensures that hospitals can introduce new viscosupplementation treatments while maintaining high care quality.

Future Insight of the Japan Viscosupplementation Market

Buyers will increasingly seek advanced treatment technologies by 2032, enhancing patient outcomes. Suppliers will gain from streamlined regulatory processes, facilitating quicker product introductions. New standards for viscosupplementation will elevate quality assurance for buyers. By 2032, multi-injection therapies are projected to represent a significant portion of total sales, potentially reaching 30%.

Market Segmentation Analysis

Japan Viscosupplementation Market report covers a detailed analysis of the following market segments:

By Product Type – Single Injection Leads, Three Injection Expected to Grow Fastest

According to Summon Dutta, Assistant Manager at 6Wresearch, with 54% of product type revenue in 2025, Single Injection was the largest category. Single Injection holds the largest share due to its widespread acceptance among patients and healthcare providers for its convenience and effectiveness. This method is commonly used in outpatient settings, making it a preferred choice for many clinics across Japan. Over 2026–2032, Three Injection is expected to post the fastest growth, at a CAGR of 9.9%. The Three Injection sub-segment is experiencing rapid growth as it offers extended relief and improved outcomes for patients with osteoarthritis. Recent studies have shown that patients receiving this regimen report higher satisfaction rates, contributing to its increasing adoption. Suppliers should focus on promoting the benefits of Three Injection protocols to capture the growing demand.

By End User – Hospitals Lead, Orthopedic Clinics/ASCs Expected to Grow Fastest

The largest end user category in 2025 was Hospitals, at 60% of revenue. Hospitals command the largest share in the market because they provide comprehensive medical services and have the infrastructure to administer viscosupplementation treatments effectively. Their ability to manage a high volume of patients seeking relief from joint pain solidifies their leading role in this sector. Orthopedic Clinics/ASCs are projected to grow fastest, at a CAGR of 9.1% during 2026–2032. Orthopedic Clinics and ASCs are witnessing the fastest growth as they specialise in joint treatments and cater to the increasing trend of outpatient care. This focus on efficient treatment options is attracting more patients who prefer quicker access to therapies. This indicates that suppliers should prioritise partnerships with Orthopedic Clinics and ASCs to meet the rising demand for specialised joint care.

Key Attractiveness of the Report

  • 10 Years of Market Numbers
  • Historical Data Starting from 2022 to 2025
  • Base Year 2025
  • Forecast Data until 2032
  • Key Performance Indicators Impacting the Market
  • Major Upcoming Developments and Projects

Key Highlights of the Report:

  • Japan Viscosupplementation Market Outlook
  • Market Size of Japan Viscosupplementation Market, 2025
  • Forecast of Japan Viscosupplementation Market, 2032
  • Historical Data and Forecast of Japan Viscosupplementation Revenues & Volume for the Period 2022-2032
  • Japan Viscosupplementation Market Trend Evolution
  • Japan Viscosupplementation Market Drivers and Challenges
  • Japan Viscosupplementation Price Trends
  • Japan Viscosupplementation Porter's Five Forces
  • Japan Viscosupplementation Industry Life Cycle
  • Historical Data and Forecast of Japan Viscosupplementation Market Revenues & Volume By Product Type for the Period 2022-2032
  • Historical Data and Forecast of Japan Viscosupplementation Market Revenues & Volume By Single Injection for the Period 2022-2032
  • Historical Data and Forecast of Japan Viscosupplementation Market Revenues & Volume By Three Injection for the Period 2022-2032
  • Historical Data and Forecast of Japan Viscosupplementation Market Revenues & Volume By Five Injection for the Period 2022-2032
  • Historical Data and Forecast of Japan Viscosupplementation Market Revenues & Volume By End User for the Period 2022-2032
  • Historical Data and Forecast of Japan Viscosupplementation Market Revenues & Volume By Hospitals for the Period 2022-2032
  • Historical Data and Forecast of Japan Viscosupplementation Market Revenues & Volume By Orthopedic Clinics/ASCs for the Period 2022-2032
  • Japan Viscosupplementation Import Export Trade Statistics
  • Market Opportunity Assessment By Product Type
  • Market Opportunity Assessment By End User
  • Japan Viscosupplementation Top Companies Market Share
  • Japan Viscosupplementation Competitive Benchmarking By Technical and Operational Parameters
  • Japan Viscosupplementation Company Profiles
  • Japan Viscosupplementation Key Strategic Recommendations

Market Covered

This report examines the market across the segments below.

By Product Type

  • Single Injection
  • Three Injection
  • Five Injection

By End User

  • Hospitals
  • Orthopedic Clinics/ASCs

Japan Viscosupplementation Market (2026-2032) FAQs

Three Injection is the fastest-growing segment at a CAGR of 9.9% during 2026–2032, followed by Orthopedic Clinics/ASCs at 9.1%.
Limited reimbursement for viscosupplementation treatments restricts patient access, while regulatory hurdles delay new product introductions, impacting availability.
Hospitals lead by end user with a 60% share in 2025, equal to USD 49.02 Million.
The PMD Act governs the approval process for viscosupplementation products, administered by the MHLW, affecting how providers introduce new therapies.
The market is expected to grow at a CAGR of approximately 7.1% during 2026–2032, with annual growth peaking at 8.1% in 2031.
The Japan Viscosupplementation Market was valued at USD 81.70 Million in 2025 and is projected to reach USD 132 Million by 2032, an increase of USD 50.30 Million.
6Wresearch actively monitors the Japan Viscosupplementation Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Japan Viscosupplementation Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Japan Viscosupplementation Market Overview

3.1 Japan Country Macro Economic Indicators

3.2 Japan Viscosupplementation Market Revenues & Volume, 2022 & 2032F

3.3 Japan Viscosupplementation Market - Industry Life Cycle

3.4 Japan Viscosupplementation Market - Porter's Five Forces

3.5 Japan Viscosupplementation Market Revenues & Volume Share, By Product Type, 2022 & 2032F

3.6 Japan Viscosupplementation Market Revenues & Volume Share, By End User, 2022 & 2032F

4 Japan Viscosupplementation Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of osteoarthritis in Japan

4.2.2 Rising geriatric population in Japan

4.2.3 Growing awareness about non-surgical treatment options for joint pain

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for viscosupplementation products in Japan

4.3.2 Limited reimbursement policies for viscosupplementation procedures

4.3.3 High cost associated with viscosupplementation treatments

5 Japan Viscosupplementation Market Trends

6 Japan Viscosupplementation Market, By Types

6.1 Japan Viscosupplementation Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 Japan Viscosupplementation Market Revenues & Volume, By Product Type, 2022-2032F

6.1.3 Japan Viscosupplementation Market Revenues & Volume, By Single Injection, 2022-2032F

6.1.4 Japan Viscosupplementation Market Revenues & Volume, By Three Injection, 2022-2032F

6.1.5 Japan Viscosupplementation Market Revenues & Volume, By Five Injection, 2022-2032F

6.2 Japan Viscosupplementation Market, By End User

6.2.1 Overview and Analysis

6.2.2 Japan Viscosupplementation Market Revenues & Volume, By Hospitals, 2022-2032F

6.2.3 Japan Viscosupplementation Market Revenues & Volume, By Orthopedic Clinics/ASCs, 2022-2032F

7 Japan Viscosupplementation Market Import-Export Trade Statistics

7.1 Japan Viscosupplementation Market Export to Major Countries

7.2 Japan Viscosupplementation Market Imports from Major Countries

8 Japan Viscosupplementation Market Key Performance Indicators

8.1 Patient satisfaction rates with viscosupplementation therapy

8.2 Number of healthcare facilities offering viscosupplementation services

8.3 Adoption rate of viscosupplementation procedures by orthopedic surgeons

9 Japan Viscosupplementation Market - Opportunity Assessment

9.1 Japan Viscosupplementation Market Opportunity Assessment, By Product Type, 2022 & 2032F

9.2 Japan Viscosupplementation Market Opportunity Assessment, By End User, 2022 & 2032F

10 Japan Viscosupplementation Market - Competitive Landscape

10.1 Japan Viscosupplementation Market Revenue Share, By Companies, 2025

10.2 Japan Viscosupplementation Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Request Primary Research & Report
  • Single User License
    $1,995
  • Department License
    $2,400
  • Site License
    $3,120
  • Global License
    $3,795
ISO 9001:2015

ISO 9001:2015 CERTIFIED

Quality Management System for market research & advisory services

Cert. No. 3050261008135Q

6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here
6WExportGTM
GLOBAL TRADE INTELLIGENCE
◎

Unlock Your Export Potential

Discover product and sector-level opportunities to identify untapped export potential.

Product / Sector Level Analysis

Find Your Next Trading Partner

Identify promising international markets and discover the right countries to expand your business.

Top Trading Partners

Know Where to Invest

Uncover high-potential markets and make informed decisions about your next investment opportunity.

Where to Invest

Stay Ahead of Competition

Understand the competitive landscape, identify key players and discover gaps in global markets.

Market Competition Analysis

Leadership Perspectives from Industry Events

6Wresearch in the News

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All